logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

TECHTRONIC IND (00669) spent HKD 6.5809 million to repurchase 50,000 shares on September 8.

date
17:33 08/09/2026
avatar
GMT Eight
Creative Power Holdings (00669) announced that on September 8, 2026, it will spend HKD 6,580,900 to buy back 50,000 shares.
TECHTRONIC IND (00669) announced that it repurchased 50,000 shares at a cost of HKD 6.5809 million on September 8, 2026.
Related Articles
HK Stock
Great Wall Motor (02333) spent approximately HKD 2.2038 million to repurchase 289,000 shares on September 8.
HK Stock
Guangzhou Baiyunshan Pharmaceutical Holdings (00874): Guangzhou Baiyunshan Pharmaceutical Holdings Bio has received the Macao Traditional Medicine Registration Certificate.
HK Stock
CSPC PHARMA (01093): The chemical innovative drug SYH2083 eye drops has received clinical trial approval in China.
Great Wall Motor (02333) spent approximately HKD 2.2038 million to repurchase 289,000 shares on September 8.
HK Stock
Guangzhou Baiyunshan Pharmaceutical Holdings (00874): Guangzhou Baiyunshan Pharmaceutical Holdings Bio has received the Macao Traditional Medicine Registration Certificate.
HK Stock
CSPC PHARMA (01093): The chemical innovative drug SYH2083 eye drops has received clinical trial approval in China.
HK Stock
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.